Detalhe da pesquisa
1.
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions.
Future Oncol
; 20(16): 1057-1067, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38348690
2.
Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.
Cancer Discov
; 12(5): 1233-1247, 2022 05 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35135829
3.
Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer.
Int J Radiat Oncol Biol Phys
; 58(4): 1017-21, 2004 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15001240